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Summary 
Cytotoxic T  cells (CTL) represent the major defense mechanism against  the spread of virus in- 
fection. It is believed that the pore-forming protein, perforin, facilitates  the entry of a series of 
serine proteases (particularly granzyme B) into the target cell which ultimately leads  to DNA 
fragmentation and  apoptosis.  We  demonstrate here that during  CTL-mediated cytolysis the 
catalytic subunit of DNA-dependent protein kinase (DNA-PKcs), an enzyme implicated in the 
repair of double strand breaks in DNA,  is specifically cleaved by an interleukin (IL)-l[3-con- 
verting  enzyme  (ICE)-like  protease.  A  serine  protease  inhibitor,  3,4-dichloroisocoumarin 
(DCI), which is known to block granzyme B  activity, inhibited CTL-induced apoptosis and 
prevented the degradation of DNA-PKcs in cells but failed to prevent the degradation of puri- 
fied  DNA-PKcs  by  CTL  extracts.  However,  Tyr-Val-Ala-Asp-CH2C1  (YVAD-CMK)  and 
other cysteine protease inhibitors prevented the degradation of purified DNA-PKcs by CTL 
extracts. Furthemmre, incubation of DNA-PKcs with granzyme B did not produce the same 
cleavage pattern observed in cells undergoing apoptosis and when this substrate was incubated 
with either CTL extracts or the ICE-like protease, CPP32. Sequence analysis revealed that the 
cleavage site in DNA-PKcs during CTL killing was the same as that when this substrate was 
exposed to CPP32. This study demonstrates for the first time that the cleavage of DNA-PKcs 
in this intact cell system is exclusively due to an ICE-like protease. 
W~n 
ile  CTLs can  kill  their targets  by several mecha- 
isms,  cell death  and  DNA  fragmentation may be 
achieved by a combination of the  actions of perforin and 
serine proteases (granzymes) present in their lysosome-like 
cytoplasmic granules (1, 2). Granule exocytosis delivers per- 
forin, a pore-forming protein to  the  surface of the  target 
cell,  causing  membrane  damage  and  ultimately cell death 
(3).  Perforin alone does not cause DNA fragmentation or 
apoptosis (4), however the granzymes, particularly granzyme 
B  (fragmentin-2), have been implicated in these processes 
(3, 5-7). Granzyme B is only expressed at high levels in ac- 
tivated CTL, lymphokine-activated killers  (LAK), and nat- 
ural killer (NK) cells (7-9). Inhibition of NK cell-induced 
cytolysis by inhibitors of serine proteases, such as isocou- 
matin, provides evidence that granzyme B or a related pro- 
tease participates in the apoptotic process (10,  11). Further- 
more,  the  generation  of mice  with  a  homozygous  null 
mutation  in  the  granzyme B  gene  demonstrates  that  this 
enzyme plays  a  critical,  non-redundant  role  in  the  rapid 
induction  of DNA  fragmentation  and  apoptosis  in  CTL 
targets  (9).  Two recent reports provide evidence that this 
role is probably indirect and is achieved by cleaving and ac- 
tivating an  IL-l~-converting enzyme (ICE)i-like protease 
(12,  13). 
Although the  degradation of DNA into oligonncleoso- 
I  Abbreviations used in this paper: DCI, 3,4-dichloroisocoumarin;  ICE, in- 
terleukin-1  B-converting  enzyme; PARK, poly  (ADP-ribose) polymerase; 
TLCK, tosyl-l-lysine  chloromethyl  ketone. 
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apoptosis for some time (14), and while a number of candi- 
date endonucleases have been reported (15-18),  the factor 
responsible for DNA fragmentation remains elusive. An in- 
triguing observation stems from the report that CTL gran- 
ule proteinases can induce the internal disintegration path- 
way in target cells (I 9, 20). One such proteinase, granzyme 
B, when  it gains access to the target cell through perforin, 
causes  fragmentation  in  DNA.  The  identity of the  target 
proteins of granzyme B  that trigger apoptosis remains un- 
clear, but  a  recent report has shown  that purified enzyme 
cleaves and activates CPP32  (12), the precursor of an ICE- 
like  protease  that  cleaves  Poly  (ADP-ribose)  polymerase 
(PARP)  during apoptosis  (21-24).  PAILP is one  of a  few 
key substrates degraded during the process ofapoptosis (23, 
25), which additionally include nuclear lamin (26, 27), U1- 
70  small nuclear ribonucleoprotein (28),  fodrin  (29),  actin 
(30), topoisomerase 1 (25, 31), and DNA-PKcs (32, 33). In 
this  study,  we  demonstrate  that  the  catalytic  subunit  of 
DNA-dependent kinase is specifically cleaved during CTL- 
mediated cytolysis. Furthermore, we show that granzyme B 
or another serine protease activates an ICE-like protease to 
cleave DNA-PKcs during this process. 
Materials  and Methods 
Reagents.  Leupeptin, E-64, pepstatin, tosyl-L-lysine  chlorom- 
ethyl  ketone  (TLCK),  tosyl-L-phenylalanine chloromethyl  ke- 
tone  (TPCK),  and  3,4-dichloroisocoumarin  (DCI),  were  ob- 
tained from  Boehringer  Mannheim  (Indainapolis, IN).  PMSF, 
iodoacetamide, and N-ethylmaleimide were from Sigma Chem. 
Co. (St. Louis, MO), and Tyr-Val-Ala-Asp-CH2C1 (YVAD-CMK) 
from Bachem (Torrance, CA). Protease inhibitor stock solutions 
were made up as follows: PMSF, 0.2 M in methanol; leupeptin, 1 
mg/ml in water; pepstatin, 1 mg/ml in methanol; E-64, 10 mg/ml 
in  a  mixture  of ethanol/water;  TLCK,  20  mM  in  methanol; 
TPCK, 40 mM in ethanol; DCI, 50 mM in DMSO; iodoaceta- 
mide, 100 mM in DMSO; N-ethylmaleimide, 100 mM in DMSO, 
and YVAD-CMK, 2 mM in DMSO. 
The  following antibodies were  used  for  immunoblotting of 
DNA-PKcs. Ab-SLY, a polyclonal antibody raised against amino 
acid region 1550-1840  of DNA-PKcs; DPK1, a polyclonal anti- 
body  raised  against  amino  acid  region  2018-2136;  Ab9607,  a 
polyclonal antibody against amino acid region 2790-3065; Ab42- 
47,  a  monoclonal  antibody  recognizing  the  kinase  (exact  se- 
quence undefined) domain and Ab-FLA an antibody against the 
whole molecule. A mouse polyclonal antibody that detects both 
Ku70 and 80 was also used (34). 
Induction of Apoptosis During Cytotoxic T Cell Killing.  The  CTL 
clone was generated as described previously (35).  Clone LC13 is 
HLA B8-restricted and it recognizes the epitope FLRGRAYGL. 
In this system CTLs act as both effector cells and target cells (35). 
For CTL-mediated cytolysis peptide FLRGRAYGL was added 
to U-shaped microtiter wells (10  raM) containing 10  s cells and 
incubated for 15 rain at 37~  before centrifugation at 200 g and 
further incubation at 37~  for the times indicated in individual 
experiments, before harvesting and extraction of proteins. An ir- 
relevant peptide EENLLDFVP,  E (10 raM) was used as a control. 
An  HLA B44-restricted clone, but not  clone LC13  recognizes 
this EBV epitope (35). 
Western Blot Analysis.  After the various treatments, cells were 
pelleted at 200 g, followed by two washes in ice-cold PBS, pH 
7.2,  and  were  then  resuspended  in  extraction buffer  (50  mM 
Tris-HCI, 150 mM NaCI, 2 mM EDTA, 2 mM EGTA, 25 mM 
NaF,  and  25  mM  [3-glycerolphosphate, pH  7.5),  0.2%  Triton 
X-100, 0.3% NP-40, 0.1  mM sodium vanadate, 0.1  mM PMSF, 
leupeptin (5 mg/ml), aprotinin (5 mg/ml), and left on ice for 10 
rain. After centrifugation at 10,000 g for 10 min at 4~  the su- 
pernatant was  collected and cell extract was  assayed for protein 
using the Bio-lLad microassay (Bio-ILad Labs., Richmond, CA). 
One-fifth  of a  volume  of 5  times  concentrated  sample  buffer 
(0.25  M  Tris-HCI, pH 6.8, 0.4 M  DTT,  5% SDS, 0.5%  Brom- 
phenol Blue, 50% glycerol) was added to each sample and boiled 
for  5  min  before  storage  at  -80~  Electrophoresis was  per- 
formed on 20 Ixg of protein sample on 8% SDS-PAGE. Proteins 
were then transferred to PVDF membranes and immunoblotting 
was performed with the appropriate antibody using an ECL kit 
(Amersham Corp., Arlington Heights,  IL).  In  some cases, blots 
were  reprobed with  different antibodies after stripping in  62.5 
mM Tris, 100 mM 2-[3-mercaptoethanol/2% SDS, pH 6.7. 
DNA-PKActivity Assay.  Whole  cell extracts were  prepared 
from CTL cells treated with FLtLGRAYGL epitope according to 
procedures described previously (36).  DNA-PK activity was  as- 
sayed with a synthetic peptide corresponding to the NHz-termi- 
nal region of human p53 gene product (PESQEAFADLWKK) at 
0.25  mM as described previously (36).  Each sample was also as- 
sayed in the presence of non-substrate peptide EPPLSEQFADL- 
WKK. Incorporation of phosphate into this peptide was less than 
5% of that for the substrate peptide, and values were subtracted 
from the appropriate samples. 
In vitro, DNA-PK Cleavage by Granzyme B and CPP32 Proteases. 
DNA-PKcs was purified as described previously (34). Ku proteins 
were also prepared as part of this protocol. Purified granzyme B 
was used in the cleavage studies (37, 38). This enzyme was shown 
to be free of other granzyme activities such as tryptase (grA) and 
Met-ase. The recombinant foml of the ICE-like protease CPP32 
was prepared as a bacterial lysate as described previously (39).  For 
cleavage of DNA-PKcs 10 ng of purified granzyme B was incu- 
bated with 0.2 Ixg of purified protein in a 20-~zl reaction volume 
containing 10 mM  Hepes, pH 7.4,  0.1  mM EDTA, and 5 mM 
DTT  for 2 h  at 37~  Incubations also contained sonicated calf 
thymus DNA (0.2  p,g). The reactions were terminated by addi- 
tion of 5 ml of loading buffer (5 times concentrated) followed by 
separation on  8%  SDS-PAGE and immunoblotting was  carried 
out with DPK1  antibody. Ku (0.2 ~g) was incubated with 10 ng 
of purified granzyme B as described for DNA-PKcs. Incubations 
also  contained DNA-PKcs  (0.2  Ixg) and  sonicated calf thymus 
DNA (0.2  p~g). Immunoblotting was carried out with polyclonal 
antibody against Ku (34).  For cleavage with CPP32, 2 btl of bac- 
terial lysate containing the  recombinant  protein was  incubated 
with DNA-PKcs (0.2  Ixg), Ku  (0.2  Ixg), and sonicated calf thy- 
nms DNA  (0.2  Ixg), in a  20-txl reaction volume containing 25 
mM Hepes, pH 7.5, 5 mM EDTA, 5 mM DTT, and 0.1% 3-[(3- 
cholamidopropyl)  dimethylamino]-l-propanesulfonate  (CHAPS) 
for 20 min at 37~ 
Preparation of Extracts  for DNA-PK Cleavage In  Vitro.  Cell  ex- 
tracts were  prepared from  CTL  clone  LC13  cells  treated with 
specific etoposide FLRGRAYGL 4 h post-treatment. Cells were 
pelleted at 200 g, followed by two washes in ice-cold PBS, pH 
7.2,  and  then  lysed by sonication in  lysis buffer containing 25 
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and  1 mM  PMSF,  2  mg/ml each  of aprotinin, leupeptin, and 
pepstatin.  The lysates were centrifuged at  16,000 g for  10 min, 
and  the  supernatants  collected  and stored  at  -20~  until re- 
quired. For cleavage of DNA-PKcs, extracts  (4 lag of total pro- 
tein) were preincubated with either leupeptin (210 raM), PMSF 
(1 mM), YVAD-CMK (10 raM), N-ethylmaleimide (5 mM), or 
iodoacetamide  (5  mM)  for 30  min at  37~  before addition of 
DNA-PKcs (0.2 Ixg) and Ku (0.2 lag) and sonicated calf thymus 
DNA (0.2 }*g) and then incubated for a further 1 h at 37~  in a 
20-ml reaction volume before  separation  on 8% SDS-PAGE and 
immunoblotting  was carried out with DPK1 antibody. 
Microsequencing.  Purified DNA-PKcs was digested with either 
CPP32  or extracts  from cells undergoing apoptosis  as described 
above.  Fragments were separated by 8% SDS-PAGE followed by 
transfer to PVDF membranes. The  150- and 120-kD fragments 
generated by DNA-PKcs cleavage  after  digestion with  CPP32 
and the  150-kD fragment generated by digestion of DNA-PKcs 
with cell extracts from CTL clone CL13 cells were sequenced us- 
ing an 473A Gas Phase sequencer (Applied Biosystems, Inc., Fos- 
ter City, CA). 
Results  and  Discussion 
We  have  recently  shown  that  the  catalytic  subunit 
(DNA-PKcs)  of DNA-dependent protein  kinase  (DNA- 
PK)  is preferentially degraded in Burkitt's lymphoma and 
other  cell  types  undergoing apoptosis  (32).  The  DNA- 
binding component of this  enzyme,  Ku,  remained intact 
and inhibitor and in vitro studies implicated the  ICE-like 
protease CPP32 in the degradation of DNA-PKcs. Mem- 
bers  of the  ICE-like family of proteases  require the  pres- 
ence of an Asp residue at the P1 position for cleavage (22), 
a  property shared  with the  cytotoxic  T  cell-specific pro- 
tease granzyme B making it unique among serine proteases 
(1).  Since  granzyme B  is  necessary  for  the  induction of 
DNA fragmentation and apoptosis in CTL-mediated kill- 
ing it was possible that DNA-PKcs might be a direct target 
for  this  enzyme or  it  could  involve the  activation of an 
ICE-like protease such as CPP32 to cleave DNA-PKcs. To 
address this question we employed Epstein-Barr Virus-spe- 
cific CTL (clone LC13) which we have demonstrated pre- 
viously to be effective targets for their own lysis when in- 
cubated in the presence of a specific epitope but not in the 
presence of irrelevant epitopes (35). The results in Fig. 1 A 
demonstrate that when CTL clone LC13 is incubated with 
cognate peptide  FLRGRAYGL a  time-dependent degra- 
dation  of DNA-PKcs  to  a  240-kD  fragment is  observed 
when immunoblotting is carried out with antibody DPK1 
prepared against amino acid region 2018-2136 of the pro- 
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Figure  1.  (A) Time course of cleavage of DNA-PKcs after exposure of 
Epstein Ban- Virus-specific CTL clone LC13 to specific peptide. The 
CTL clone was generated as described previously  (35). Extracts were pre- 
pared as  described in Materials and Methods, electrophoresed on 8% 
SDS-PAGE and immunoblotting was performed with DPK1 antibody 
which recognizes a peptide containing amino  acids 2018-2136 in DNA- 
PKcs using an ECL kit (Amersham). (B) Time course in the presence of irrelevant  peptide. Clone LC13 was also incubated in the presence of an irrele- 
vant peptide (EENLLDFVRE, 10 mM). An HLA B44-restricted clone but not clone LC13 recognizes  this EBV epitope (35). (C) Lack of degradation of 
Ku70 and Ku80, the DNA-binding component of DNA-PK, during apoptosis in CTL clone LC 13 in the presence of specific peptide with time after ex- 
posure. (D) Time course of DNA-PK activity  in CTL clone LC13 incubated  with specific epitope (FLRGRAYGL).  DNA-PK activity  was assayed with 
a synthetic  peptide (PESQEAFADLWKK)  substrate as described  previously  (47). Each sample was also assayed in the presence ofnon-substrate  peptide EPP- 
LSEQFADLWKK. 
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clone LC13 undergoing apoptosis. (;ells were exposed to the following 
inhibitors pepstatin (3.6 raM), leupeptin  (210 raM), E-64  (50  raM), 
PMSF (I raM), I)C1 (200 raM), and TPCK (200 raM) fbr 30 rain before 
exposure to specific peptide for I5 rain followed by harvesting 4 h later. 
I)NA-PKcs was detected with I)PK1 antibody. 
tein (40). After 4 h  incubation with FLRGR.AYGL ~60% 
degradation  of DNA-PKcs  is  observed  which  agrees  well 
with  the  extent  of specific lysis  at  this  time  point  as mea- 
sured by chromium release (35). The size of this fragment is 
comparable to that occurring in other cell types exposed to 
a  variety  of agents  that  cause  apoptosis  (32).  Exposure  of 
CTL  clone  LC13  to  a  non-specific  epitope  (EENLLD- 
FVIR.E) which fails to elicit lysis  in this clone did not cause 
any degradation of DNA-PKcs up to 8 h incubation (Fig.  1 
/3). Under these conditions there was no evidence for deg- 
radation  of either Ku70 or Ku80,  the DNA-binding com- 
ponent of DNA-PK (Fig.  1 C). 
As  expected,  the  activity  of DNA-PK  in  CTL  clone 
LC 13 was markedly reduced with time after the addition of 
cognate epitope  FLIR.GRAYGL, being reduced  to 31%  of 
that in untreated cells after 4 h  (Fig.  1 D). This reduction in 
activity paralleled the degradation of I)NA-PKcs and is also 
in agreement with data observed in etoposide treated Bur- 
kitt's lymphoma cells  (32). In an attempt to identify the na- 
ture  of the  protease  involved  in  DNA-PKcs  degradation, 
we employed a number ofprotease inhibitors.  TPCK (cys- 
teine  and  serine  protease  inhibitor)  and  DC1  (serine  pro- 
tease inhibitor)  prevented apoptosis during CTL killing (re- 
sults  not  shown),  and  were  also  capable  of inhibiting  the 
degradation  of DNA-PKcs,  while  other inhibitors  such  as 
leupeptin,  pepstatin,  PMSF,  and  E64 failed  to  do  so  (Fig. 
2).  It was not possible  to  use  iodoacetamide  and  _NLethyl- 
maleimide,  two  cysteine  protease  inhibitors,  with  whole 
cells  because of their toxicity. These results suggested that a 
serine type protease, such as granzyme B, might be respon- 
sible for the degradation of DNA-PKcs (41).  To substanti- 
ate  this  further,  purified  DNA-PKcs  was  exposed  to 
granzyme  B.  In the  presence  of Ku,  DNA-PKcs was  de- 
graded  to  a  fragment  of similar  size  (240  kD)  to  that  ob- 
served  in  CTL  undergoing  apoptosis,  as  detected  with 
DPK1 antibody (Fig. 3 A, lane 3).  When Ku was excluded 
from the incubation mix cleavage was less effective with an 
intermediate-sized  fragment  being  evident  (Fig.  3  A,  lane 
2).  Use of an antibody specific for Ku (34) demonstrated that 
there  was  some  cleavage  of  both  Ku70  and  Ku80  by 
granzyme B  under these  conditions  (Fig.  3  B,  lane  2).  No 
degradation  of Ku was observed in CTL  (Fig. 3  B, lane  3) 
or Burkitt's cells (Fig. 3  B, lane  4) undergoing apoptosis or 
when the purified complex was exposed to CPP32 (lane 5). 
Use  of an  antibody  that  detected  all  regions  of DNA- 
PKcs  (Ab-FLA)  also  revealed  only  a  single  degradation 
fragment  of 240  kD  after  incubation  of DNA-PKcs with 
granzyme  B  (Fig.  3  C,  lane  2).  Furthermore,  the  salne 
cleavage  pattern  was  observed  when  purified  DNA-PKcs 
was  incubated  with  granzyme  B  at  10  ng  over  the  time 
range 0-3 h  (Fig. 3  D; lanes  I-6) or when purified DNA- 
PKcs was incubated with granzyme B  over the dose range 
0-20  ng for a period  of 2  11  (Fig.  3  E;  lanes  1-6).  Use of 
other antibodies specific for different regions of DNA-PKcs 
also failed to detect fragments other than the 240-kD flag- 
merit  (results  not shown).  When Ab-FLA was used to de- 
tect DNA-PKcs in extracts from CTL undergoing apopto- 
sis two fragments of~240  and 150 kD were observed (Fig. 
3  C, lane 3).  This pattern was similar to that observed with 
extracts from Burkitt's lymphoma cells  undergoing apopto- 
sis induced by etoposide  (Fig.  3  C,  lane  4).  The  ICE-like 
protease  CPP32,  when  incubated  with  purified  1)NA- 
PKcs,  also produced fragments of 240  and  150 kD and an 
additional  strong band was observed  at  12(1 kD  (Fig.  3  C, 
lane  5).  It was not possible  to  detect  the  120-kD  band  m 
either  the  CTL  or Burkitt's  cell  lanes  under  these  condi- 
tions.  However,  we  have previously shown  that  a  weaker 
120-kD band is produced during apoptosis in Burkitt's cells 
(32).  To further distinguish between  a role for granzyme B 
or an  ICE-like protease  in  this  process,  extracts  were  pre- 
pared from CTL exposed to specific peptide for 4 h. As ob- 
served in cells  undergoing apoptosis, these extracts also de- 
graded DNA-PKcs to a 240-kD fragment as detected with 
DPK1  antibody  (Fig.  4,  lane  2).  YVAD-chloromethylke- 
tone  (CMK),  a specific inhibitor of ICE-like proteases,  io- 
doacetamide  and  N--ethylmaleinlide,  cysteine  protease  in- 
hibitors,  prevented the degradation of DNA-PKcs by CTL 
extracts  (Fig.  4,  lanes  5-7,  respectively).  Neither DC1  nor 
TPCK were able to prevent the degradation ofl)NA-PKcs 
by  CTL  extracts  (Fig.  4,  lanes  8  and  9,  respectively),  in 
contrast  to  the  results  obtained  in whole  cells  where  both 
inhibitors  were  effective in  preventing  DNA-PKcs degra- 
dation  and  onset  of apoptosis  (Fig.  2).  These  data  suggest 
that DNA-PKcs is  a  direct target for an  ICE-like protease 
in  CTL-mediated  cytolysis  and  that  granzyme  B  partici- 
pates  in  the  process  further  upstream,  possibly  activating 
the ICE-like protease. 
We have previously shown that both extracts from Bur- 
kitt's lymphoma cells  undergoing etoposide-induced apop- 
tosis  and  CPP32  incubated  with  DNA-PKcs  gave  rise  to 
150-  and  120-kD  fragments  (32).  Furthermore,  NH,-ter- 
minal  sequencing  revealed  that  the  site  of cleavage  that 
generated the  150-kD fragment was DEVDSN  (amino ac- 
ids 2709-2713) in both cases.  The 120-kD fragment is pro- 
duced  from  within  the  150-kD  fragment  by  cleavage  at 
DWVD,I,G  (amino acids 2979-2983).  Both sequence  mo- 
tifs  would be  expected  to be recognized by ICE-like pro- 
teases  (22,  42).  Microsequencing  of the  150-kD  fragment 
generated  from  incubation  of DNA-PKcs  with  CTL  ex- 
622  Cleavage ofl)NA-dependent Protein  Kinase in Cytotoxic T-Cell Killing Figure 3.  (A) Cleavage of purified DNA-PKcs by granzyme B in the 
presence or absence ofKu. Immunoblotfing was carried out with DPK1 
antibody.  (B) Cleavage of purified Ku70 and Ku80 by granzyme B. (C) 
Cleavage of purified DNA-PKcs by granzyme B and CPP32  and com- 
parison with degradation  of DNA-PKcs in cells undergoing apoptosis. 
Fragments were detected  by immunoblotting using Ab-FLA antibody 
that recognizes the whole of DNA-PKcs. Lane  1, purified DNA-PKcs. 
Lane 2, DNA-PKcs (0.2 l.tg) incubated fur 2 h with granzyme B (10 ng) 
in the presence  of Ku and DNA. Lane 3, extract prepared  from  clone 
13  incubated  with  specific peptide  for  3  h.  Lane  4,  extract  prepared 
from Burkitt's  lymphoma  cells exposed to etoposide  (68 raM)  for 3 h, 
Lane 5, purified  DNA-PKcs ((I,2 ~tg) incubated  with CPP32  (2 I.tl of 
bacterial lysate) for 20 rain in the presence of Ku and DNA. (D) Time 
course of cleavage of purified  DNA-PKcs by granzyme  B in the pres- 
ence of Ku and comparison  with degradation  of purified DNA-PKcs by CPP32  in the presence ofKu. hmnunoblotting was carried out with Ab-FLA 
antibody.  Lanes 1-6, purified I)NA-PKcs (0.2 p,g) incubated with granzyme B (10 ng) in the presence of Ku and DNA for 0, 0.5,  1,  1.5, 2, 3 h. Lane  7, 
I)NA-PKcs (0.2 I.tg) incubated with CPP32 (2 Ixl of  bacterial lysate) for 20 rain in the presence of Ku and DNA. (E) Effect of different doses ofgranzyme 
B on cleavage of purified DNA-PKcs in the presence of Ku after 2 h incubation  and comparison with degradation  of purified DNA-PKcs by CPP32  in 
the presence ofKu. hnnmnoblotting was carried out with Ab-FLA antibody.  Lanes 1-6, purified 1)NA-PKcs  (0.2 I,  tg) incubated  with granzyme B at 0, 
1.25, 2.5, 5,  lf), and 20 ng for 2 h in the presence of Ku and DNA. Lane 7, DNA-PKcs ((I.2 ~g} incubated with CPP32 (2 I~1 of bacterial lysate) for 20 
rain in the presence of Ku and DNA. 
tracts  demonstrated  that  cleavage  occurred  at  the  same 
DEVDSN  site, providing further support  for the direct in- 
volvement of an ICE-like protease  in DNA-PKcs  degrada- 
tion during T  cell killing. 
In  the  present  study  we  have  demonstrated  for  the  first 
time  that  DNA-PKcs  is  an  important  substrate  in  CTL- 
mediated  cytolysis and  its cleavage in this intact cell system 
is  exclusively due  to  an  ICE-like protease.  Although  both 
the catalytic and regulatory' subunits of DNA-PK  are cleaved 
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by granzyme B  in vitro,  this  enzyme is not a  physiological 
substrate  for granzyme B.  Direct cleavage of DNA-PKcs  is 
mediated by an  ICE-like protease,  and  granzyme  B, which 
plays  a  major  role  in  CTL  killing,  appears  to  be  involved 
upstream  from this protease.  Recent studies  suggest that  this 
is the case. Darmon  et al.  (12)  demonstrated  that granzyme 
B  cleaved in vitro translated  CPP32,  and  the cleaved prod- 
uct was  active and  capable  of cleaving PARP  an important 
substrate  in  apoptosis.  Proteolytic  activation  of CPP32  by Figure 4.  Effect  ofinhibitors on degradation of purified DNA-PKcs by 
extracts prepared from CTL clone LC13 undergoing apoptosis induced 
with  specific peptide epitope. Cell extracts were prepared from CTL 
clone LC13 cells treated with specific peptide, 4 h post-treatment, lmmu- 
noblotting was carried out with DPK1 antibody. 
granzyme B  was also demonstrated by Quan et al.  (13).  In 
addition, the Nedd2 precursor can be processed by purified 
granzyme  B  (Harvey,  N.L., J.A.  Trapani,  and  S.  Kumar, 
unpublished  observation).  CPP32  has  been  shown  to 
cleave PARP (21-24),  and DNA-PKcs represents  only the 
second substrate  for this  enzyme described  here  in  CTL- 
killing  and  during  apoptosis  in  Burkitt's  lymphoma  cells 
treated  with  etoposide  (32).  Since  both  of these  enzymes 
are implicated in DNA repair  (43-50)  their loss would fa- 
cilitate  the  onset  of DNA  fragmentation  and  apoptosis. 
However,  since  PARP  knockout  nfice  (51)  and  SCID 
mice (lacking active DNA-PKcs) are able to develop essen- 
tially normally it seems likely that these proteins are not the 
only targets during apoptosis.  Indeed, other substrates  such 
as nuclear lamin,  fodrin, actin,  and the U1-70-kD protein 
are cleaved during apoptosis (26-30). As suggested by Mar- 
tin and Green  (52)  "too many cuts in too many places re- 
sult in a critical change in the cell and it suddenly collapses 
into apoptotic death." All of these data point to the impor- 
tance of several critical targets, not all of which are required 
to  be  degraded  in  response  to  a  single  apoptotic  stimulus. 
We have shown that, in CTL killing, activation of an ICE- 
like  protease  by  granzyme  B  or  another  serine  protease 
leads  to  the  degradation  of  one  such  critical  substrate 
(DNA-PKcs). Clearly, it is important to identify other sub- 
strates involved in this form ofT cell killing in order to un- 
derstand the nature of the pathway(s) involved. 
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